Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (181-190 of 261) with videos related to

Pageof 27
Sort By:
International Journal of Cancer|August 26, 2016
Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
BMC Cancer|June 23, 2019
Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control studyKerri Beckmann, Beth Russell, Debra Josephs, et al.
Cancer Causes & Control : CCC|June 20, 2012
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Ruben Hermans, Karl Michaelsson, et al.
Journal of Oncology|February 27, 2023
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base SwedenGincy George, Hans Garmo, Jan Adolfsson, et al.
International Journal of Molecular Epidemiology and Genetics|June 23, 2012
Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS studyDivya Seth, Hans Garmo, Annette Wigertz, et al.
NPJ Breast Cancer|June 2, 2021
Risk of primary lung cancer after adjuvant radiotherapy in breast cancer-a large population-based studyAnna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, et al.
Journal of the National Cancer Institute|April 5, 2007
Prostate-specific antigen levels as a predictor of lethal prostate cancerKatja Fall, Hans Garmo, Ove Andrén, et al.
Breast (Edinburgh, Scotland)|December 6, 2023
Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based studyEmma Söderberg, Fredrik Wärnberg, Anna-Karin Wennstig, et al.
Pageof 27

Showing results (181-190 of 261) with videos related to

Sort By:
Pageof 27
International Journal of Cancer|August 26, 2016
Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
BMC Cancer|June 23, 2019
Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control studyKerri Beckmann, Beth Russell, Debra Josephs, et al.
Cancer Causes & Control : CCC|June 20, 2012
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Ruben Hermans, Karl Michaelsson, et al.
Journal of Oncology|February 27, 2023
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base SwedenGincy George, Hans Garmo, Jan Adolfsson, et al.
International Journal of Molecular Epidemiology and Genetics|June 23, 2012
Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS studyDivya Seth, Hans Garmo, Annette Wigertz, et al.
NPJ Breast Cancer|June 2, 2021
Risk of primary lung cancer after adjuvant radiotherapy in breast cancer-a large population-based studyAnna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, et al.
Journal of the National Cancer Institute|April 5, 2007
Prostate-specific antigen levels as a predictor of lethal prostate cancerKatja Fall, Hans Garmo, Ove Andrén, et al.
Breast (Edinburgh, Scotland)|December 6, 2023
Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based studyEmma Söderberg, Fredrik Wärnberg, Anna-Karin Wennstig, et al.
Pageof 27